News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Sommadossi Jean-Pierre
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2022 |
4
| Sommadossi Jean-Pierre (President, CEO, and Chairman) has filed a Form 4 on Atea Pharmaceuticals, Inc.|
Txns:
| Granted 378,033 options to buy
@ $7.14, valued at
$2.7M
|
|
| 06/30/2021 |
4
| Sommadossi Jean-Pierre (Director) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Granted 26,000 options to buy
@ $5.59, valued at
$145.3k
|
|
| 02/01/2021 |
4
| Sommadossi Jean-Pierre (President, CEO, and Chairman) has filed a Form 4 on Atea Pharmaceuticals, Inc.|
Txns:
| Granted 640,000 options to buy
@ $73, valued at
$46.7M
|
|
| 11/03/2020 |
4
| Sommadossi Jean-Pierre (President, CEO, and Chairman) has filed a Form 4 on Atea Pharmaceuticals, Inc.|
Txns:
| Converted 750,000 shares
@ $0
Converted 750,000 convertible preferred
@ $0 |
|
| 06/26/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/27/2019 |
4
| Sommadossi Jean-Pierre (Director) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Granted 8,896 options to buy
@ $7.63, valued at
$67.9k
|
|
| 06/27/2018 |
4
| Sommadossi Jean-Pierre (Director) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Converted 52,581 shares
@ $0
Converted 35,258 shares
@ $0
Converted 52,581 options to buy
@ $0
Converted 35,258 options to buy
@ $0 |
|
| 02/11/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|